DPP-4 inhibitors |
Nauck MA et al 2007 Diab Ob Metab 9:194-205 |
−0.84 |
−1.25 |
|
Rosenstock J et al 2006 Clin Therap 28:1556-1568 |
−0.88 |
0.3 |
|
Charbonnel B et al 2006 Diabetes Care 29:2638-2643 |
−0.7 |
−0.65 |
|
Aschner P et al 2006 Diabetes Care 29:2632-2637 |
−0.62 |
−0.2 |
|
Scott R et al 2007 Int J Clin Pract 61:171-180 |
−0.46 |
0.4 |
|
Raz I et al 2006 Diabetologia 49:2564-2571 |
−0.46 |
−0.6 |
|
Goldstein BJ et al 2007 Diabetes Care 30:1979-1987 |
−0.69 |
0 |
|
Pi-Sunyer FX et al 2007 Diab Res Clin Prac 76:132-138 |
−0.8 |
−0.4 |
|
Bosi E et al 2007 Diabetes Care 30:890-895 |
−0.9 |
0.2 |
|
Ahren B et al 2004 Diabetes Care 27:2874-2880 |
−0.6 |
−0.4 |
|
Ristic S et al 2005 Diab Ob Metab 7:692-698 |
−0.5 |
−0.07 |
|
Rosenstock J et al 2007 Diabetes Care 30:217-223 |
−1.1 |
−0.3 |
|
Rosenstock J et al 2007 Diab Ob Metab 9:175-185 |
−1.1 |
0.2 |
|
Schweizer A et al 2007 Diab Med 24:955-961 |
−1 |
0.3 |
Thiazolidinediones |
Smith SR et al 2004 Metab Clin Exp 54:24-32 |
−1.0 |
3.7 |
|
Lautamaki R et al 2005 Diabetes 54:2787-2794 |
−0.4 |
1.9 |
|
Kahn SE et al 2006 N Engl J Med 355:2427-2443 |
−0.6 |
1.1 |
|
Goldberg RB et al 2005 Diabetes Care 28:1547-1554 |
−0.6 |
1.6 |
|
Goldberg RB et al 2005 Diabetes Care 28:1547-1554 |
−0.7 |
2.0 |
|
Bajaj M et al 2004 Int J Ob 28:783-789 |
−1.2 |
3.1 |
|
Bajaj M et al 2003 Diabetes 52:1364-1370 |
−1.1 |
3.0 |
|
Stocker DJ et al 2007 Amer Heart J 153:445.e1-445.e6 |
−1.1 |
1.6 |
|
Pavo I et al 2003 J Clin Endocrinol Metab 88:1637-1645 |
−1.3 |
0.7 |
|
Miyazaki Y et al 2002 J Clin Endocrinol Metab 87:2785-2791 |
−1.4 |
3.0 |
|
Tan M et al 2005 Diabetes Care 28:544-550 |
−1.5 |
1.8 |
|
Gastaldelli A et al 2007 Am J Physiol Endocrinol Metab 292:E871-E883 |
−1.4 |
3.5 |
|
Miyazaki Y et al 2004 J Clin Endocrinol Metab 89:4312-4319 |
−1.7 |
3.6 |
|
Miyazaki Y et al 2001 Diabetes Care 24:710-719 |
−1.7 |
3.6 |
|
Raskin P et al 2001 Diabetes Care 24:1226-1232 |
−1.1 |
5.3 |
|
Phillips LS et al 2001 Diabetes Care 24:308-315 |
−1.5 |
3.3 |
|
St John Sutton M et al 2002 Diabetes Care 25:2058-2064 |
−1.1 |
5.0 |
|
Miyazaki Y et al 2002 Diabetes Care 25:517-523 |
−1.8 |
4.5 |
Metformin |
Viljanen APM et al 2005 J Clin Endocrinol Metab 90:6523-6528 |
−0.6 |
−1.8 |
|
Tiikkainen M et al 2004 Diabetes 53:2169-2176 |
−0.7 |
−2 |
|
Kahn SE et al 2006 N Engl J Med 355:2427-2443 |
−.76 |
−1.8 |
|
Pavo I et al 2003 J Clin Endocrinol Metab 88:1637-1645 |
−1.5 |
−2.4 |
|
Tessier D et al 1999 Metabolism 48:697-903 |
−1 |
−2.6 |
|
Garber AJ et al 2002 Diab Ob Metab 4:201-208 |
−1.03 |
−0.6 |
Metformin |
Jones KL et al 2002 Diabetes Care 25:89-94 |
−1 |
−1.5 |
|
Stocker DJ et al 2007 Amer Heart J 153:445.e1-445.e6 |
−1.19 |
−2 |
|
Hallsten K et al 2002 Diabetes 51:3479-3485 |
−0.7 |
−2 |
|
Del Prato 2003 Acta Diabetol |
−1.02 |
−0.7 |
Glyburide |
Kahn SE et al 2006 N Engl J Med 355:2427-2443 |
−0.8 |
1 |
|
Garber AJ et al 2002 Diab Ob Metab 4:201-208 |
−1.24 |
1.7 |
|
Garber AJ et al 2003 J Clin Endocrinol Metab 88:3598-3604 |
−1.9 |
2 |
|
Sung BH et al 1999 Hypertension 34:83-88 |
−0.4 |
0 |
|
Barnett AH et al 2006 Diabetes Care 29:1818-1825 |
−2.05 |
2 |
|
Hanefeld M et al 2004 Diabetes Care 27:141-147 |
−1.1 |
1.9 |
|
Marbury T et al 1999 Diab Res Clin Pract 43:155-166 |
−0.9 |
2.9 |
|
Kitabchi AE et al 2000 Am J Med Sci 19:143-148 |
−0.7 |
1 |
|
Forst T et al 2003 Exp Clin Endocrinol Diabetes 111:97-103 |
−0.1 |
0.3 |
|
Garber AJ et al 2006 Diab Ob Metab 4:201-208 |
−1.5 |
3 |
|
Jain R et al 2006 Pharmacotherapy 26:1388-1395 |
−2.3 |
2 |